NASDAQ: ACER Long Term Investor Alert: Investigation of Potential Wrongdoing at Acer Therapeutics Inc.

San Diego, CA -- (SBWIRE) -- 02/03/2020 -- An investigation on behalf of current long term investors in Acer Therapeutics Inc. (NASDAQ: ACER) shares over possible breaches of fiduciary duty by certain officers and directors was announced.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.